Update - Zayed National Museum and Bahrain Launch Six-Week Archaeologica… Transport - Dubai RTA Introduces Five-Star Rating System for Taxi Companies… Weather - Rain Expected in Some Areas on November 16 as Temperatures Drop…

Send an Inquiry

Fill in the details below and our team will get back to you.

Business 1 min read 64 views

To Fight Coronavirus Gilead Sciences Is A Company With Permission

Gilead Sciences is a biopharmaceutical company targeted on research, development, and commercialization of innovative medicines to develop care of patients struggling from life-threatening diseases. The company commonly focuses on treatments to HIV, AIDS, liver disease, and severe cardiovascular and respiratory diseases, inclusive of Coronavirus.

The company has been known mainly for HIV treatment since 1990, when Michael L. Riordan and Erik De Clerq were accompanied by scientist Antonin Holy. The three of them were referred to as "The Holy Trinity". Antonn Holy performed an essential role in innovating drugs to treat HIV and Hepatitis B.

After 5 years of its existence, Gilead Sciences entered NASDAQ. Back then, the company already cooperated with Mr. Holy, whose drugs were and still are among the most successful and best-earning drugs ever sold by Gilead Sciences.

The company's recent success is permission to use its experimental drug treatment of Coronavirus. The U.S. enabled a procedure, which allows emergency treatment with unapproved drugs.

Gilead Sciences keeps developing treatment for HIV and is similarly progressing towards drug application to improve immune function of a patient, which leads to viral remission and minimizes patient's reactions in the absence of antiretroviral therapy.

Since the starting of 2020, shares of the company profited more than 14%. The main reason is drug treatment to combat COVID-19. Yet, similarly to other companies, Gilead Sciences has experienced deterioration due to investment spillovers in March. In accordance to Alpho analysis, Gilead is not exception in recent sentiments that make investors to choose less risky types of assets.

Main representatives of Gilead Sciences declared that HIV treatment continues to be the ultimate long-term goal for research and development efforts of the biopharmaceutical company.

Milosh Pham
Chief Analyst
Alpho

Trading is risky and your entire investment may be at risk. TCs available at https://alpho.com/

Related News

More on Business

View all

Comments (0)

Join the conversation

No comments yet. Be the first to share your thoughts!

More News

See all
Business

Big 5 Global 2026: Six French companies to showcase advanced construction technologies in Dubai

Six French companies will present their construction technologies and expertise at Big 5 Global 2026, scheduled to take place from November 23 to 26 at the Dubai World Trade Centre. Supported by Business France, AITENDERS, ALPHI ME, ARIADIS, COMUS, CSTB and QUADRA will showcase solutions across...

Nov 16, 2026 · 3 min
Education

JICE connects UAE students with higher education opportunities in Japan at NAJAH Abu Dhabi 2026

The Japan International Cooperation Center (JICE) welcomed approximately 1,200 visitors to the Japan Pavilion at NAJAH Abu Dhabi 2026, held from October 18 to 21 at ADNEC Centre Abu Dhabi. The initiative introduced students and families to higher education opportunities in Japan through...

Nov 16, 2026 · 2 min
Real Estate

Emirates REIT reports 12% rise in property income as Funds from Operations nearly double in Q3 2026

Emirates REIT (CEIC) PLC reported strong financial results for the nine months ended September 30, 2026, with year-on-year growth in property income, operating profit and Funds from Operations (FFO), alongside improvements in its balance sheet. Equitativa (Dubai) Limited, the manager of Emirates...

Nov 16, 2026 · 2 min
Education

Almasar Alshamil Education outlines vision for future of learning at Education Investment MENA 2026

Almasar Alshamil Education Chief Executive Officer Majed Al Mutairi joined regional education leaders at Education Investment MENA 2026 in Dubai, where discussions focused on the future of learning, the role of technology and the importance of collaboration across the education sector. Held on...

Nov 16, 2026 · 2 min
Trusted by

Our Associates

Brands and organisations that work with Day of Dubai.